Nixon J V
Arch Intern Med. 1983 Aug;143(8):1567-71.
The identification of mural thrombus in patients with left ventricular aneurysm and mural thrombus probably warrants consideration of long-term anticoagulation. In patients with acute, large, anterior or anteroapical, transmural myocardial infarctions, serial noninvasive examinations are warranted to define a group of patients at high risk for the development of left ventricular aneurysm and/or mural thrombus. Anticoagulants should be considered in patients in whom mural thrombi develop as a complication of their infarction. Patients with congestive cardiomyopathy should be considered for long-term anticoagulation. These recommendations are all tempered by the realization that the use of anticoagulant therapy is not without its own risks. The decision to anticoagulate must be balanced against each individual patient's suitability for such therapy and the individual likelihood of the development of side effects.
识别左心室室壁瘤患者的附壁血栓,附壁血栓可能需要考虑长期抗凝治疗。对于急性、大面积、前壁或前心尖透壁性心肌梗死患者,有必要进行系列无创检查,以确定一组发生左心室室壁瘤和/或附壁血栓风险较高的患者。对于梗死并发附壁血栓的患者应考虑使用抗凝剂。充血性心肌病患者应考虑长期抗凝治疗。这些建议都因认识到抗凝治疗并非没有自身风险而有所缓和。决定是否进行抗凝治疗必须权衡每个患者对此类治疗的适用性以及出现副作用的个体可能性。